This has happened with some transactions.
e.g. Synthorx bought early Phase 1 in 2019 by Sanofi.
https://www.sanofi.com/en/media-room/press-releases/2019/2019-12-09-06-00-00-1957603
Sanofi have now put that program on back burner in Phase 2 ( efficacy not meeting expectations ).
https://www.biopharmadive.com/news/sanofi-synthorx-il2-cancer-drug-delay/635206/
Ann: Race Leadership Changes, page-338
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.030(1.72%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.71 | $86.73K | 50.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3270 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.72 | 405 | 1 |
View Market Depth
| Last trade - 13.31pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |